Meriam Kabbaj
Technik-/Wissenschafts-/F&E-Leiter bei GENFIT
Aktive Positionen von Meriam Kabbaj
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GENFIT | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2022 | - |
Versantis AG
 Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | Direktor/Vorstandsmitglied | 01.01.2015 | - |
| Geschäftsführer | 01.01.2015 | - | |
| Gründer | 01.01.2015 | - |
Karriereverlauf von Meriam Kabbaj
Ausbildung von Meriam Kabbaj
| University of Montréal | Doctorate Degree |
Statistik
International
| Kanada | 2 |
| Schweiz | 2 |
| Frankreich | 2 |
Operativ
| Doctorate Degree | 1 |
| Director/Board Member | 1 |
| Chief Operating Officer | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GENFIT | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Versantis AG
Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | Health Technology |
- Börse
- Insiders
- Meriam Kabbaj
- Erfahrung
